BOSTON, April 26, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. RYTM, a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, May 3, 2023 to report its first quarter 2023 financial results and provide a corporate update.To access the live conference call, please dial (866) 374-5140 (domestic) or (404) 400-0571 (international) and refer to conference ID 79122322.
Rhythm Pharmaceuticals to Report First Quarter 2023 Financial Results on Tuesday, May 3, 2023
